Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial-Reference-Cited by-同舟云学术

Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial

Published:2019-08 Issue:4 Volume:38 Page:325-331
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Jha Sanjeev Kumar^ORCID,Mishra Manish K.,Saharawat Kuldeep,Jha Praveen,Purkayastha Shubham,Ranjan Ravish

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s12664-019-00949-4.pdf

Reference32 articles.

1. Talebi A, Abadi B, Kusters JG. Management of Helicobacter pylori infections. BMC Gastroenterol. 2016;16:94.

2. Adlekha S, Chadha T, Krishnan P, Sumangala B. Prevalence of helicobacter pylori infection among patients undergoing upper gastrointestinal endoscopy in a medical college hospital in Kerala, India. Ann Med Health Sci Res. 2013;3:559–63.

3. Sodhi JS, Javid G, Zargar SA, et al. Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India. J Gastroenterol Hepatol. 2013;28:808–13.

4. Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012;136:549–62.

5. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review;Helicobacter;2024-01

2. Treatment of Helicobacter pylori infection 14‐day concomitant quadruple therapy versus triple therapy: A parallel double‐blind randomized controlled trial;Health Science Reports;2023-10

3. Crosstalk between Helicobacter pylori and gastrointestinal microbiota in various gastroduodenal diseases—A systematic review;3 Biotech;2023-08-14

4. Choosing optimum regimen for treating Helicobacter pylori infection: Regional data may be the quintessential guide;Indian Journal of Gastroenterology;2023-07-19

5. Adding Nitazoxanide to standard triple therapy improves eradication rate of Helicobacter Pylori in post covid-19 antibiotic resistant era: a single center open-label randomized controlled trial;2023-05-29